Alliancebernstein L.P. Allogene Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 210,078 shares of ALLO stock, worth $432,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares

210,078

Previous 210,078 -0.0%

Holding current value

$432,760

Previous $489,000 20.25%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.23 - $4.38 $123,252 - $242,082	55,270 Added 35.7%	210,078 $489,000
Q4 2023 Feb 14, 2024	BUY	$2.28 - $3.5 $23,005 - $35,315	10,090 Added 6.97%	154,808 $496,000
Q3 2023 Nov 14, 2023	SELL	$3.17 - $5.96 $59,057 - $111,034	-18,630 Reduced 11.41%	144,718 $458,000
Q2 2023 Aug 15, 2023	BUY	$4.53 - $6.74 $282,853 - $420,845	62,440 Added 61.88%	163,348 $811,000
Q1 2023 May 15, 2023	BUY	$4.92 - $8.21 $72,816 - $121,508	14,800 Added 17.19%	100,908 $498,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $11.11 $2,309 - $4,566	-411 Reduced 0.48%	86,108 $541,000
Q3 2022 Nov 15, 2022	SELL	$10.32 - $17.28 $5.6 Million - $9.38 Million	-542,988 Reduced 86.26%	86,519 $934,000
Q2 2022 Aug 15, 2022	BUY	$6.78 - $12.28 $3.65 Million - $6.62 Million	538,699 Added 593.23%	629,507 $7.18 Million
Q1 2022 May 13, 2022	BUY	$7.65 - $15.29 $765 - $1,529	100 Added 0.11%	90,808 $827,000
Q4 2021 Feb 14, 2022	SELL	$13.13 - $24.52 $41.1 Million - $76.7 Million	-3,126,577 Reduced 97.18%	90,708 $1.35 Million
Q3 2021 Nov 10, 2021	BUY	$21.01 - $27.64 $1.06 Million - $1.4 Million	50,655 Added 1.6%	3,217,285 $82.7 Million
Q2 2021 Jul 30, 2021	BUY	$23.49 - $35.8 $14.7 Million - $22.4 Million	625,071 Added 24.59%	3,166,630 $82.6 Million
Q1 2021 May 06, 2021	SELL	$25.79 - $39.02 $1.22 Million - $1.85 Million	-47,299 Reduced 1.83%	2,541,559 $89.7 Million
Q4 2020 Feb 08, 2021	BUY	$25.24 - $43.45 $16.5 Million - $28.4 Million	654,713 Added 33.85%	2,588,858 $65.3 Million
Q3 2020 Nov 12, 2020	BUY	$32.38 - $44.96 $7.48 Million - $10.4 Million	231,025 Added 13.56%	1,934,145 $72.9 Million
Q2 2020 Aug 13, 2020	SELL	$18.39 - $54.04 $5.03 Million - $14.8 Million	-273,604 Reduced 13.84%	1,703,120 $72.9 Million
Q1 2020 May 14, 2020	BUY	$18.22 - $28.25 $3.65 Million - $5.66 Million	200,421 Added 11.28%	1,976,724 $38.4 Million
Q4 2019 Feb 18, 2020	BUY	$24.82 - $31.4 $4.04 Million - $5.11 Million	162,594 Added 10.08%	1,776,303 $46.1 Million
Q3 2019 Nov 14, 2019	BUY	$26.11 - $32.99 $2.19 Million - $2.77 Million	84,060 Added 5.5%	1,613,709 $44 Million
Q2 2019 Aug 14, 2019	BUY	$25.56 - $31.09 $4.21 Million - $5.12 Million	164,642 Added 12.06%	1,529,649 $41.1 Million
Q1 2019 May 14, 2019	BUY	$24.82 - $32.54 $1.98 Million - $2.59 Million	79,580 Added 6.19%	1,365,007 $39.5 Million
Q4 2018 Feb 13, 2019	BUY	$22.5 - $33.3 $28.9 Million - $42.8 Million	1,285,427 New	1,285,427 $34.6 Million

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $296M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Allogene Therapeutics, Inc. Transaction History